Dual loss of both the SMARCA4 and the SMARCA2 occurs in SCCOHT and in other neoplasms such as thoracic sarcomas, undifferentiated and dedifferentiated endometrial carcinomas, and rare undifferentiated uterine sarcomas [17]. Here, SMARCA2 is linked to uterine corpus sarcoma.